Corrigendum to 'detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives'

Affiliations

• ¹ Université de Paris, IAME, INSERM, Paris, France; Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France.
• ² Université de Paris, IAME, INSERM, Paris, France; Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France. Electronic address: benoit.visseaux@aphp.fr.
• ³ Université de Paris, IAME, INSERM, Paris, France; Centre for Clinical Investigation, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France.
• ⁴ Université de Paris, IAME, INSERM, Paris, France; Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France.
• ⁵ Université de Paris, IAME, INSERM, Paris, France; Tropical and Infectious Diseases Department, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France.
• ⁶ Virology, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Paris, France.
• ⁷ Université de Paris, IAME, INSERM, Paris, France; Emergency Department, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital Paris, France.